TY  - JOUR

T1  - Characterization of type 2N von Willebrand disease using molecular and phenotypic analysis

JO  - Blood Coagulation & Fibrinolysis

UR  - http://dx.doi.org/10.1097/00001721-199504000-00079

PY  - 1995/04/01

AU  - Nesbitt IM

AU  - Guilliatt AM

AU  - Goodeve AC

AU  - Preston FE

AU  - Peake IR

ED  - 

DO  - DOI: 10.1097/00001721-199504000-00079

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 6

IS  - 2

SP  - 178

EP  - 178

Y2  - 2025/04/28

ER  -